Progesterone receptor expression in neurofibromas

Cancer Research

Volumn 63, Issue 4, 2003, Pages 752-755

  McLaughlin, Margaret E ^a,b,c,d   Jacks, Tyler ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGESTAGEN; ESTROGEN RECEPTOR; MIFEPRISTONE; PROGESTERONE RECEPTOR;

ARTICLE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROFIBROMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL; TISSUE DISTRIBUTION;

HUMANS; IMMUNOHISTOCHEMISTRY; NEUROFIBROMA; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; SCHWANN CELLS; SKIN NEOPLASMS;

EID: 0037442427     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cichowski, K., and Jacks, T. NF1 tumor suppressor gene function: narrowing the GAP. Cell, 104: 593-604, 2001.
2. Serra, E., Rosenbaum, T., Winner, U., Aledo, R., Ars, E., Estivill, X., Lenard, H. G., and Lazaro, C. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations. Hum. Mol. Genet., 9: 3055-3064, 2000.
3. Zhu, Y., Ghosh, P., Charnay, P., Burns, D. K., and Parada, L. F. Neurofibromas in NF1: Schwann cell origin and role of tumor Environment. Science (Wash. DC), 296: 920-922, 2002.
4. Hudson, S. M. Neurofibromatosis: historical perspective, classification and diagnostic criteria. In: S. M. Hudson and R. A. C Hughes (eds.), The Neurofibromatoses, pp. 1112. London: Chapman & Hall Medical, 1944.
5. Gutmann, D. H., Aylsworth, A., Carey, J. C., Korf, B., Marks, J., Pyeritz, R. E., Rubenstein, A., and Viskochil, D. The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA, 278: 51-57, 1997.
6. Scheithauer, B. W., Woodruff, J. M., and Erlandson, R. A. Tumors of the Peripheral Nervous System, pp. 177-405. Washington, D. C.: Armed Forces Institute of Pathology, 1999.
7. Martuza, R. L., MacLaughlin, D. T., and Ojemann, R. G. Specific estradiol binding in schwannomas, meningiomas, and neurofibromas. Neurosurgery (Baltimore), 9: 665-671, 1981.
8. Chaudhuri, P. K., Walker, M. J., Das Gupta, T. K., and Beattie, C. W. Steroid receptors in tumors of nerve sheath origin. J. Surg. Oncol., 20: 205-206, 1982.
9. Concolino, G., Liccardo, G., Conti, C., Panfili, C., and Giuffre, R. Hormones and tumours in central nervous system (CNS): steroid receptors in primary spinal cord turnouts. Neurol. Res., 6: 121-126, 1984.
10. Chetkowski, R., Sakamoto, H., MacLusky, N., Merino, M., and Schwartz, P. E. Solitary pelvic neural tumors with high steroid receptor content. Gynecol. Oncol., 20: 43-52, 1985.
11. Ojeda, S. R. Female reproductive function. In: S. R. Ojeda (ed.), Textbook of Endocrine Physiology, Fourth Ed., pp. 202-242. Oxford and New York: Oxford University Press, 2000.
12. Jaffe, R. B. Neuroendocrine-metabolic regulation of pregnancy. In: R. L. Barbieri (ed.), Reproductive Endocrinology, Fourth Ed., pp. 751-784. Philadelphia: W. B. Saunders Company, 1999.
13. Griffin, J. E. Male reproductive function. In: S. R. Ojeda (ed.), Textbook of Endocrine Physiology, Fourth Ed., pp. 243-264. Oxford and New York: Oxford University Press, 2000.
14. Giangrande, P. H., and McDonnell, D. P. The A and B isoforms of the human progesterone receptor: two functionally different transcription factors encoded by a single gene. Recent Prog. Horm. Res., 54: 291-313, 1999.
15. Perry, A., Roth, K. A., Banerjee, R., Fuller, C. E., and Gutmann, D. H. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors. Am. J. Pathol., 159: 57-61, 2001.
16. Jung-Testas, I., Schumacher, M., Robel, P., and Baulieu, E. E. Demonstration of progesterone receptors in rat Schwann cells. J. Steroid Biochem. Mol. Biol., 58: 77-82, 1996.
17. Koenig, H. L., Schumacher, M., Ferzaz, B., Thi, A. N., Ressouches, A., Guennoun, R., Jung-Testas, I., Robel, P., Akwa, Y., and Baulieu, E. E. Progesterone synthesis and myelin formation by Schwann cells. Science (Wash. DC), 268: 1500-1503, 1995.
18. Guennoun, R., Benmessahel, Y., Delespierre, B., Gouezou, M., Rajkowski, K. M., Baulieu, E. E., and Schumacher, M. Progesterone stimulates Krox-20 gene expression in Schwann cells. Brain Res. Mol. Brain Res., 90: 75-82, 2001.
19. Kioussi, C., and Gruss, P. Making of a Schwann. Trends Genet., 12: 84-86, 1996.
20. Jessen, K. R., and Mirsky, R. Schwann cells and their precursors emerge as major regulators of nerve development. Trends Neurosci., 22: 402-410, 1999.
21. Koide, S. S. Mifepristone. Auxiliary therapeutic use in cancer and related disorders. J. Reprod. Med., 43: 551-560, 1998.